葵花药业：11月18日召开董事会会议

Core Viewpoint - Kew Flower Pharmaceutical announced the convening of its 13th board meeting of the 5th session on November 18, 2025, to discuss product research and development initiatives [1] Company Summary - For the first half of 2025, Kew Flower Pharmaceutical's revenue composition was 99.61% from the pharmaceutical industry and 0.39% from other businesses [1] - As of the report date, Kew Flower Pharmaceutical has a market capitalization of 8.7 billion yuan [1]